William Blair & Company’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$390K	Sell	77,000 -37,500	-33%	-$190K	﹤0.01%	1163
2025 Q1	$606K	Buy	114,500 +102,500	+854%	+$542K	﹤0.01%	1033
2024 Q4	$81.1K	Buy	+12,000	New	+$81.1K	﹤0.01%	1551